ZyVersa Therapeutics, Inc. (ZVSA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$8.72M2024: -$7.52M2025: -$5.11M-$5.11M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$5.11M+32.0%
2024-$7.52M+13.8%
2023-$8.72M